Lumida
/IMAX
⌘K
Imax Corp

Imax Corp

IMAX
$52.09USD+1.44%+0.74 today

MARKET CAP

2.9B

P/E (TTM)

80.1x

FWD P/E

DAY RANGE

$51 – $52

52W RANGE

$31
$56

AI Summary

Stalk
StalkMedium

IMAX remains in a Stage 2 advancing regime, trading above rising EMAs and SMAs. Price has consolidated sideways, holding near the mid-range of its recent advance and above the 50-day SMA. Short-term momentum is neutral with no clear timing edge, while medium-term bias stays bullish. The preferred approach is to stalk pullbacks into the rising EMA cluster around the 50-day SMA for an actionable entry.

  • FY25 revenue rose 40% YoY to $1.28B; adjusted EBITDA margin reached 45%.
  • The Odyssey opening weekend delivered $52M with 75% theater occupancy domestically.
  • Blockbuster dependence poses downside if major releases underperform.
Full analysis →
STATEMENT·Income statement
USD · GAAP
METRICFY 2021FY 2022FY 2023FY 2024FY 2025TREND
Sales, Adj.$254.9M$300.8M$374.8M$352.2M$410.2M
YoY %+86.0%+18.0%+24.6%-6.0%+16.5%
P / Sales4.1x2.8x2.2x3.9x5.0x
EV / Sales5.2x4.1x3.3x4.9x5.8x
Gross Profit, Adj.$134.4M$156.4M$214.3M$190.2M$246.2M
YoY %+524.0%+16.3%+37.1%-11.3%+29.4%
Margin %52.7%52.0%57.2%54.0%60.0%
EV / Gross Profit9.8x7.9x5.7x9.1x9.6x
EBITDA, Adj.$64.8M$56.3M$113.5M$113.1M$156.2M
YoY %+201.5%-13.2%+101.6%-0.3%+38.0%
Margin %25.4%18.7%30.3%32.1%38.1%
EV / EBITDA20.3x21.8x10.7x15.3x15.2x
EBIT$10.5M$-4.8M$50.4M$43.9M$84.2M
YoY %+108.7%-145.9%+1142.6%-13.0%+92.0%
Margin %4.1%-1.6%13.4%12.5%20.5%
EV / EBIT125.3x-254.2x24.2x39.5x28.1x
Net Income$-22.3M$-22.8M$25.3M$26.1M$34.9M
YoY %+84.5%-2.1%+211.1%+2.9%+33.8%
Net Margin-8.8%-7.6%6.8%7.4%8.5%
EPS (GAAP)-$0.38-$0.40$0.46$0.48$0.63
YoY %+84.4%-5.3%+215.0%+4.3%+31.3%